Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A photo journal of the #PrEP4All activists at the House hearings on Gilead, PrEP, and Truvada pricing.
The CDC holds the patents to Truvada-as-PrEP, but hasn’t asked for a dime in royalties from Gilead. This is costing taxpayers billions. Why?
Watch Gregg Gonsalves explain how his work affects public health, human rights and health inequities. [VIDEO]
A social media recap of AIDS 2018.
Robert R. Redfield, MD, is a longtime HIV researcher. But he’s also controversial.
A new analysis finds that Gilead Sciences’ updated version of its key antiretroviral tenofovir may not actually offer any safety benefits.
HIV groups ask: If Silence=Death, where is the HIV community’s voice resisting the war against immigrants in the United States?
An update from the director of the Basic Science, Vaccines and Cure Project at Treatment Action Group (TAG).
Many advocates and HIV organizations pay their respects to AIDS activist Mathilde Krim on social media.
And it’s not survivor’s guilt, explains ACT UP veteran turned film director Vincent Gagliostro.
The Treatment Action Group paid tribute to those working to end the HIV/AIDS epidemic.
Stephen Barker’s portraits show early AIDS activists, minus all the anger
Consensus statement warns of “dangerous consequences” if HIV crime laws rely on a person’s undetectable status and treatment adherence.
AIDS groups spell out how the proposed massive budget cuts will harm both local and global funding.
You can sign the statement and “stand united with others who are fighting for their lives.”
Outlined in a Health Affairs Blog post, the recommendations come from the Treatment Action Group and the Fair Pricing Coalition.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.